ATE129286T1 - Klonierung von streptomyces avermitilis genen zur biosynthese von avermectin und verfahren zu ihrer verwendung. - Google Patents

Klonierung von streptomyces avermitilis genen zur biosynthese von avermectin und verfahren zu ihrer verwendung.

Info

Publication number
ATE129286T1
ATE129286T1 AT90303300T AT90303300T ATE129286T1 AT E129286 T1 ATE129286 T1 AT E129286T1 AT 90303300 T AT90303300 T AT 90303300T AT 90303300 T AT90303300 T AT 90303300T AT E129286 T1 ATE129286 T1 AT E129286T1
Authority
AT
Austria
Prior art keywords
avermectin
biosynthesis
streptomyces avermitilis
cloning
disclosed
Prior art date
Application number
AT90303300T
Other languages
English (en)
Inventor
Keith M Gewain
Philip S Paress
Douglas J Macneil
Carolyn L Ruby
Stanley S Streicher
Tanya Macneil
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/490,723 external-priority patent/US5252474A/en
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of ATE129286T1 publication Critical patent/ATE129286T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/76—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Actinomyces; for Streptomyces
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1003—Transferases (2.) transferring one-carbon groups (2.1)
    • C12N9/1007—Methyltransferases (general) (2.1.1.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/181—Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C12P19/62—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
    • C12P19/623—Avermectin; Milbemycin; Ivermectin; C-076

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AT90303300T 1989-03-31 1990-03-28 Klonierung von streptomyces avermitilis genen zur biosynthese von avermectin und verfahren zu ihrer verwendung. ATE129286T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33114689A 1989-03-31 1989-03-31
US07/490,723 US5252474A (en) 1989-03-31 1990-03-14 Cloning genes from Streptomyces avermitilis for avermectin biosynthesis and the methods for their use

Publications (1)

Publication Number Publication Date
ATE129286T1 true ATE129286T1 (de) 1995-11-15

Family

ID=26987612

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90303300T ATE129286T1 (de) 1989-03-31 1990-03-28 Klonierung von streptomyces avermitilis genen zur biosynthese von avermectin und verfahren zu ihrer verwendung.

Country Status (9)

Country Link
EP (1) EP0391594B1 (de)
JP (1) JP3063910B2 (de)
AT (1) ATE129286T1 (de)
AU (1) AU626398B2 (de)
CA (1) CA2013524C (de)
DE (1) DE69023036T2 (de)
ES (1) ES2079436T3 (de)
IE (1) IE69375B1 (de)
NZ (1) NZ233116A (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2071066A1 (en) * 1991-06-19 1992-12-20 Ali Shafiee Fk-900520 enzymatic and/or microbial methylation products
FI942725A7 (fi) * 1993-12-16 1995-06-17 Pfizer Haaraketjuista alfaketohappodenydrogenaasikompleksia koodaavia geenejä Streptomyces avermitiliksesta
PL194270B1 (pl) * 1998-02-13 2007-05-31 Pfizer Prod Inc Wyizolowana cząsteczka polinukleotydowa, cząsteczka oligonukleotydowa, zrekombinowany wektor, komórka gospodarza, wyizolowany produkt genu AveC S. avermitilis, wyizolowany produkt homologu genu AveC S. hygroscopicus, sposób wytwarzania zrekombinowanego produktu genu AveC, sposób wytwarzania zrekombinowanego produktu homologu genu AveC, cząsteczka polinukleotydowa, wektor do zastępowania genu, sposób identyfikowania mutacji otwartej ramki odczytuAveC, sposób wytwarzania nowych szczepów S. avermitilis, szczep S. avermitilis i sposób wytwarzaniaawermektyn
US6248579B1 (en) 1998-02-13 2001-06-19 Pfizer Inc Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins
GB9814622D0 (en) * 1998-07-06 1998-09-02 Biotica Tech Ltd Polyketides,their preparation,and materials for use therein
DE19838848A1 (de) 1998-08-26 2000-03-02 Weber & Weber Gmbh & Co Kg Pyrrolizidinalkaloidfreie Petasites enthaltende Zusammensetzung
US6197591B1 (en) * 1998-09-14 2001-03-06 Pfizer Inc. Streptomyces avermitilis regulatory genes for increased avermectin production
JP2000245457A (ja) 1999-02-24 2000-09-12 Kitasato Inst:The エバーメクチンアグリコン合成酵素遺伝子
JP2003506022A (ja) * 1999-07-30 2003-02-18 メルク エンド カムパニー インコーポレーテッド アベルメクチンアグリコングリコシル化に関するストレプトマイセスアベルミチリスの遺伝子のクローニング
WO2001012821A1 (en) 1999-08-12 2001-02-22 Pfizer Products Inc. Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins
US20040101936A1 (en) * 2000-02-24 2004-05-27 Hirofumi Endo Process for producing avermectin derivative

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE434277B (sv) * 1976-04-19 1984-07-16 Merck & Co Inc Sett att framstella nya antihelmintiskt verkande foreningar genom odling av streptomyces avermitilis
US4429042A (en) 1978-09-08 1984-01-31 Merck & Co., Inc. Strain of Streptomyces for producing antiparasitic compounds
US4703009A (en) * 1983-03-08 1987-10-27 Merck & Co., Inc. RDNA cloning vector pVE1, deletion and hybrid mutants and recombinant derivatives thereof products and processes
EP0118367B1 (de) * 1983-03-08 1989-04-26 Merck & Co. Inc. Rekombinant-DNS Klonierungsvektor pVE1, Deletions- und Hybridmutante, und rekombinante Derivate derselben Produkte und Verfahren
EP0262154A1 (de) * 1985-12-17 1988-04-06 Lubrizol Genetics Inc. Isolierung von genen für die biosynthese von polyketid-antibiotika

Also Published As

Publication number Publication date
IE901184L (en) 1990-09-30
ES2079436T3 (es) 1996-01-16
DE69023036D1 (de) 1995-11-23
AU626398B2 (en) 1992-07-30
IE69375B1 (en) 1996-09-04
EP0391594B1 (de) 1995-10-18
CA2013524C (en) 2005-12-06
DE69023036T2 (de) 1996-06-13
CA2013524A1 (en) 1990-09-30
JP3063910B2 (ja) 2000-07-12
AU5244590A (en) 1990-10-04
JPH0315391A (ja) 1991-01-23
EP0391594A3 (de) 1992-01-02
EP0391594A2 (de) 1990-10-10
NZ233116A (en) 1994-09-27

Similar Documents

Publication Publication Date Title
Kreft et al. Recombinant plasmids capable of replication in B. subtilis and E. coli
EP0329822A3 (en) Nucleic acid amplification process
DK120091D0 (da) Tripelstrenget nukleinsyre og anvendelse heraf
ES2119744T3 (es) Nitrato reductasa como marcador de acremonium chrysogenum.
DE69023036D1 (de) Klonierung von Streptomyces avermitilis Genen zur Biosynthese von Avermectin und Verfahren zu ihrer Verwendung.
CA2065003A1 (en) Enhanced nucleic acid amplification process
AU4431196A (en) Dna integration by transposition
EP0331939A3 (de) Verfahren und Zusammensetzungen zum Widerstand gegen Retroviralinfektionen
DE3629890A1 (de) Mikroorganismen und plasmide fuer die 2,4-dichlorphenoxyessigsaeure (2,4-d)-monooxigenase - bildung und verfahren zur herstellung dieser plasmide und staemme
AU9058091A (en) Preparation of nucleic acid samples
CA2016358A1 (en) Method for the synthesis of ribonucleic acid (rna)
RU94046200A (ru) Последовательности днк, производные последовательностей днк, плазмиды, способ применения последовательностей, способ применения плазмид, трансгенные растения
NZ307444A (en) Polyphenol oxidase genes from lettuce and banana
DE69736673T2 (de) Rifamycin biosynthese genkluster
WO1999042589A3 (en) Insecticidal toxins from photorhabdus
AU531722B2 (en) Stable high copy number plasmids
US5079151A (en) Production of branched RNA-linked multi-copy single-stranded DNA using permeabilized cells
DK0857220T3 (da) Sekvensmodifikation af oligonucleotidprimere til manipulering af ikke-templateret nucleotidaddition
EP0712933A3 (de) Für die FseI Restriktionsendonuklease kodierende, isolierte DNA und Verfahren zu ihren Herstellung
Bujard et al. Insertion of transcriptional elements outside the replication region can interfere with replication, maintenance, and stability of ColE1-derived plasmids
EP0147145A3 (de) Streptomycete Wirtzellen mit beschränkter Restriktionsaktivität
EP4544037B1 (de) Crispr-cas9 basierte linearisierung von plasmid dna-templaten
ATE118816T1 (de) Verfahren zur herstellung von acci- restriktionsendonuklease und -methylase.
WO1994000473A3 (en) Pentavalent synthesis of oligonucleotides containing stereospecific alkylphosphonates and arylphosphonates
AU2371188A (en) Cloning afl ii restriction endonuclease and methylase from anabaena flos-aquae

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties